Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) chief executive Manuel Llobet and chief financial officer Nick Wykeman talked to Proactive about its latest results and the upcoming clinical trials for its peanut and grass pollen allergy vaccines.
The company also announced a £17mln funding round to pay for the trials and bolster its balance sheet.
#ProactiveInvestors #AllergyTherapeutics #aim #otc